Navigation Links
CTI Issues Statement Regarding Tosedostat Clinical Trial
Date:6/24/2013

SEATTLE, June 25, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today issued the following statement regarding the notification of the U.S. Food and Drug Administration (the "FDA") partial clinical hold on tosedostat (IND 075503), the Company's aminopeptidase inhibitor under development for the treatment of blood-related cancers, that is being studied in an investigator-sponsored trial and not by CTI. CTI's primary development programs are the ongoing Phase 3 trial of pacritinib, the Company's JAK2/FLT3 inhibitor being evaluated for patients with myelofibrosis, and the post-approval commitment study of PIXUVRI® (pixantrone).

This is a partial clinical hold of only part of the clinical work requested under the investigational new drug ("IND") application. Under a partial clinical hold, although a specific protocol or part of a protocol is not allowed to proceed, other parts of such protocol or other protocols are allowed to proceed under the IND. With this partial clinical hold, the Company may not enter new patients onto any of the ongoing tosedostat protocols until agreement is reached with the FDA.

After a study has been placed on partial clinical hold, the sponsor provides additional information and discusses the adverse event with the FDA to understand whether or not it was associated with the drug or due to another cause. The Company has begun work to comply with the FDA request and expects to be able to submit these data to the FDA in the coming weeks. For additional information, please refer to the Current Report on Form 8-K filed by the Company on June 24, 2013.

Recent Tosedostat Publication
In March 2013, Lancet Oncology published results from the OPAL Phase 2 study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML). The trial showed that once-daily oral tosedostat resulted in a disease contro
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
2. Celsion Corporation Issues Statement Regarding Misleading Blog Entry
3. Zydus Pharmaceuticals USA Inc. Issues Voluntary Nationwide Recall of Warfarin 2 mg Tablets, Lot MM5767, Expiration Date June 2014, Due to Oversized Tablets
4. Endeavor Power Corporation Issues Corrections on two of its earlier Press Releases dated January 9, 2013 and March 8, 2013
5. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
6. ISPE Patient Initiative Issues Survey Regarding Patient Experience with Clinical Materials
7. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
8. American Academy of Ophthalmology Issues Statement on Provisions to Pharmaceutical Compounding Quality and Accountability Act
9. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
10. BD Issues 2012 Sustainability Report
11. TNI BioTech, Inc. Corporations CEO Issues Letter to Shareholders Discussing Recent Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: ... commitments from institutional investors to purchase an aggregate ... stock in an at-the-market registered direct offering, led ... The Company entered into definitive purchase agreements with ... to sell an aggregate of 3,603,603 shares of ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, ... and technologies must be able to protect ... (IP). (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ... nature of the Medical Device Industry, it ... industry sectors of cases involving IP infringement. ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence ... a Medical Fitness Center by the Medical Fitness ... and fitness centers to achieve their full potential. ... only certified fitness center in the western suburbs ... "The certification means the Cadence Fitness & Health ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... 16 Reportlinker.com announces that a ... in its catalogue. , ... Market Outlook To 2014: Policy environment, ... , http://www.reportlinker.com/p0155347/Reportlinker-Adds-The-Middle-Eastern-Pharmaceutical-Market-Outlook-To-2014-Policy-environment-market-structure-competitive-landscape-growth-opportunities.html ...
... Oct. 16 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) ... meeting at 1:30 p.m. eastern time on Oct. 19, 2009. ... the management presentation which will follow. During that presentation, management ... , The webcast can be accessed via a link on ...
Cached Medicine Technology:Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 2Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 3Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 4Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 5Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 6Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 7Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 8Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 9Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 10Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 11
(Date:4/14/2014)... called microRNA 135b, is a vital ,worker, employed by ... bowel cancers. , Drugs targeted at the microRNA could ... once, while tests for it could identify patients with ... research was carried out by an international team including ... the University of Glasgow and Ohio State University in ...
(Date:4/14/2014)... the world, many people live and work in dim ... sunlight. And as the global population continues to rise ... only spread. , To alleviate the problem, Egyptian ... sunlight onto narrow streets and alleyways. The panel is ... an angle, where it spreads sunlight onto the street ...
(Date:4/14/2014)... Ohio Heart patients with beliefs about health that ... skip sessions of cardiac rehabilitation, new research suggests. , ... of these beliefs referred to as "irrational health ... was associated with lower adherence to a prescribed cardiac ... Doubting the preventive power of the flu vaccine or ...
(Date:4/13/2014)... program for adolescent girls in Kenyan slums sharply ... who live in an environment where women have ... new study shows. , The findings, by researchers ... Packard Children,s Hospital Stanford and the nongovernmental organization ... in combating an appallingly common hazard among girls ...
(Date:4/11/2014)... researchers from the University of California, San Diego School ... (CCSB) at the Dana-Farber Cancer Institute has uncovered a ... autism interact with many more partners than previously known. ... involve alternatively spliced forms of autism genes found in ... the April 11, 2014 online issue of Nature ...
Breaking Medicine News(10 mins):Health News:'MicroRNA' could be key target for bowel cancer treatment 2Health News:Let the sun shine in: Redirecting sunlight to urban alleyways 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4Health News:Splice variants reveal connections among autism genes 2
... Ennis ... of Paxil who have suffered from serious Paxil side effects such as: Birth Defects, ... toll free at 1-800-856-6405 or go to the firm’s website at http://www.ennislaw.com ... ...
... a new electrophoretic method for detecting MIRCERA and other ... SARCOSYL-PAGE, has specifically enhanced sensitivity for MIRCERA, but does ... other EPOs. Details of this study, funded by ... in the latest issue of Drug Testing and ...
... , NAPA, Calif., Dec. 15 Senetek PLC (OTC Bulletin Board: SNKTY), ... target the science of healthy aging, today announced that shareholders had approved all three ... on December 14, 2009. Voting results were as follows: , , ... Votes ...
... , Proceeds will be donated to the Lupus Foundation of ... Dec. 15 Julian Lennon, son of the legendary John Lennon, ... to raise funds for research on the disease lupus. From now ... "LUCY" at iTunes will be donated to the Lupus Foundation of ...
... associated with lower dementia risk, research finds , TUESDAY, Dec. ... hormone that regulates appetite, may guard against Alzheimer,s disease, new ... may be one of many agents that we use to ... Dr. Sudha Seshadri, an associate professor of neurology at Boston ...
... , , Prostate cancer tests promised ... Health Network calls on Congress to ensure that healthcare reform ... of insurance companies in 37 states. , Prostate cancer screening ... individuals who are identifiable as high risk, including African American ...
Cached Medicine News:Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3Health News:Researchers discover novel method for detecting MIRCERA 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2
An enzyme-linked immuno-sorbent assay for the detectionand quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
... and Stabilizer Plastazote® with plastic ... closure straps. Chin cradle reduces ... may be interchanged for individualized ... the standard Philadelphia Collar for ...
Bougie Urethrotomes for slitting the female urethra and for meatus stenosis in males...
Optical Mini Urethrotome for telescope 3.3 mm, 0...
Medicine Products: